fda glp-1 compounding crackdown september 2025 ignites new fight over copycat weight loss drugs BREAKING NEWS in the compounding

For plan sponsors and fiduciaries, the lesson is clear: if you cant produce it, you cant defend it

The FDA has also cautioned that compounded GLP-1s are not FDA-approved, may have inconsistent dosing and could pose safety risks

This is where serious researchers come to win

Certain contraindications must be ruled out before treatment initiation

As patients and clinicians explore these medications' broader metabolic impacts, questions arise about potential effects on cortisolthe stress hormone linked to central weight gain and insulin resistance

Acetyl-L-carnitine promotes peripheral nervous system comfort and supports healthy mood, energy and overall well-being